Allergy & Clinical Immunology Perspective and Journal Articles

• The Medication That Patients Were Itching to Try Dr William Balistreri comments on the considerable promise of novel therapies for intractable cholestatic pruritus.
  Medscape Gastroenterology, May 23, 2022
• Best & Worst Places to Practice 2022 Some states offer lots of perks and temptations for physician practices, although each doctor has their own priorities that make some places more desirable.
  Medscape Features Slideshows, May 20, 2022
• How Medicine Is Failing a Nation in Pain   Pain is central to every specialty, and we all played a part in the opioid crisis, says Dr Haider Warraich, author of The Song of Our Scars: The Untold Story of Pain.
  Medscape, May 20, 2022
• Should You Get a Second COVID-19 Vaccine Booster?   WebMD's Chief Medical Officer, John Whyte, MD, discusses the latest guidelines and recommendations on getting your second COVID-19 vaccine booster.
  WebMD, May 16, 2022
• Medscape Allergist & Immunologist Compensation Report 2022 Medscape's Allergist & Immunologist Compensation Report 2022 explores income sources, pay gaps, and attitudes about work as COVID's impact on medical practices declines.
  Medscape Features Slideshows, May 13, 2022
• Waning Effectiveness of mRNA Vaccines Against COVID-19 The findings in this report underscore the importance of receiving a third dose of mRNA COVID-19 vaccine and suggest that an additional dose may be necessary to sustain protection.
  Morbidity & Mortality Weekly Report, May 13, 2022
• The Case for Post-COVID Steroids   Dr F. Perry Wilson cautions against changing practice on the basis of a single study.
  Medscape, May 12, 2022
• Risk of Herpesvirus and Serious Infections in Atopic Dermatitis This study suggests that atopic dermatitis is associated with an increased risk of hospital admission with infections, opportunistic infections and herpesvirus infections in both children and adults.
  The British Journal of Dermatology, May 10, 2022
• Outcomes Among Adults With SARS-CoV-2 Infection Delta/Omicron This CDC report reaffirms that COVID-19 vaccination, particularly a booster dose, continues to be critical in mitigating the health care burden of the Omicron variant.
  Morbidity & Mortality Weekly Report, May 09, 2022
• Alarming Global Rise in Pediatric Hepatitis: Expert Q&A Pediatric hepatologist Dr William Balistreri shares his insights on the mysterious, possibly adenovirus-related outbreak.
  Medscape Gastroenterology, May 05, 2022
• Cure, Prevent, or Manage All Disease: The Chan Zuckerberg Initiative's Bold Plan Is Already Working   Dr Eric Topol sits down with Mark Zuckerberg and Priscilla Chan to talk about the next phase of their ambitious Chan Zuckerberg Initiative.
  Medscape, April 28, 2022
• Think About Antibiotics Like We Think About Chemotherapy Healthcare providers can be somewhat cavalier about ordering antibiotics. Maybe if we thought about antibiotics like we think about chemotherapy, we'd do better with our prescribing practices.
  Medscape Blogs, April 27, 2022
• Antipsychotics Associated With Severe Asthma Exacerbation Risk Asthma patients receiving typical antipsychotic treatment may realize a higher risk of severe asthma exacerbations, but the effect may be dose related.
  BMC Pulmonary Medicine, April 27, 2022
• Effectiveness of a Third Dose of mRNA Vaccines Against COVID-19 Receipt of a third mRNA vaccine dose was highly effective at preventing moderately severe and severe COVID-19 during Delta and Omicron predominance, according to this report.
  Morbidity & Mortality Weekly Report, April 25, 2022
• Infographic: Physician Incomes Gain, Pay Gaps Remain The Medscape Physician Compensation Report 2022 infographic shows growth in physician income, specialties with biggest pay gains, and pay disparities between men and women and between ethnic groups.
  Medscape, April 22, 2022
• COVID-19 Incidence During Delta and Omicron Variant Emergence This report confirms that COVID-19 vaccination protected against SARS-CoV-2 infection, with protection against hospitalization and death remaining high, even as the Omicron variant became predominant.
  Morbidity & Mortality Weekly Report, April 22, 2022
• Animal Reservoirs, Immunocompromised Hosts: COVID Dangers Ahead   Stanford's Benjamin Pinsky on the potential for even more transmissible and pathogenic versions of the SARS-CoV-2 virus to arise.
  Medscape, April 21, 2022
• Cancer Groundshot: From Blog Post to ASCO Session Bishal Gyawali, MD, PhD, looks at the rise of the cancer groundshot.
  Medscape Oncology, April 20, 2022
• Atopic Dermatitis Highlights From AAD 2022   Dr Lindsay Strowd discusses key reports on atopic dermatitis from AAD 2022, including data on AD-associated COVID-19 and malignancy risk, and how AD affects sleep patterns in adults and behavior in children.
  Medscape, April 18, 2022
• Third mRNA Vaccine in Preventing COVID-19 Hospitalization According to this CDC report, a third dose of an mRNA COVID-19 vaccine significantly increases effectiveness against hospitalization among adults without and with immunocompromising conditions.
  Morbidity & Mortality Weekly Report, April 18, 2022